Back to Authors

Kaila, S.

A5111020730 | I4391767992

Mayo Clinic

Janssen Scientific Affairs, LLC, Horsham, United Kingdom

Citations 2

P16 HEALTH-RELATED QUALITY OF LIFE FOR FRAIL TRANSPLANT-INELIGIBLE PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA TREATED WITH DARATUMUMAB, LENALIDOMIDE AND DEXAMETHASONE: SUBGROUP ANALYSIS OF MAIA TRIAL

HemaSphere | November 16, 2023 | Volume: 7 | Issue: S2 | Pages: 18-19

10.1097/01.hs9.0000936192.21618.f2

PB2003: REAL-WORLD DURATION OF USE AND DOSING FREQUENCY OF DARATUMUMAB IN PATIENTS WITH MULTIPLE MYELOMA IN THE U.S.

HemaSphere | June 24, 2022 | Volume: 6 | Issue: No issue available | Pages: 1874-1875

10.1097/01.hs9.0000850844.58786.ec